Kavita sarin biography template
Two surveys with identical questions but different question ordering were used to assess the secondary objective. I love the way things are done here. Although cSCC contributes to substantial morbidity and mortality in high-risk individuals, deployment of otherwise effective chemoprevention of cSCC is limited by toxicities. Careful exam, polite people.
These results show that the digital health tool DORA can easily be used by patients to send photos to their dermatologist, which could reduce unnecessary clinical visits. The most common malignancies amongst MPM patients include breast, prostate, thyroid, soft tissue, brain, kidney, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia.
Sarin, and David F. Genetic testing and counseling hold paramount importance in the clinical context of suspected hereditary melanoma, facilitating risk assessment, personalized surveillance strategies, and informed decision-making. The study findings highlight key diagnostic biomarkers for sebaceous carcinoma and suggest that immunotherapy and modulation of cholesterol biosynthesis could be effective treatment strategies.
Sarin is an outstanding physician, caring with an excellent skills as a physician. Adverse effects included grade 2 transaminitis and grade 4 leukopenia with a grade 3 infection. Previous studies have demonstrated an association between 21 distinct genetic loci and BCC risk. Nature Reviews. Assessment of readability and content of patient-initiated google search results for epidermolysis bullosa.
Did not seem to understand my needs. She told me in simple terms. Abstract Cutaneous neurofibromas cNF are considered one of the highest burdens of neurofibromatosis type 1 NF1. Absolute IFN1 score was independently associated with muscle and skin disease activity, interstitial lung disease, and anti-MDA5 antibodies.
Biography
Kavita Sarin, M.D./Ph.D., is a Professor of Dermatology and is the Director of the Stanford Nibble Cancer Genetics Program at the Stanford Cancer Academy. She has an academic interest in Precision Improve, focused on the integration of genetic and clinical patient data to inform susceptibility, prognosis, and treatments in skin cancer and other rare dermatologic disorders.
Her lab applies cutting-edge sequencing and imaging technologies to better understand skin cancer and rare medicine skin diseases. She sees patients in medical dermatology at Portola Valley and the Stanford Cancer Organization.
Professional Summary
Education & Certifications
- Internship: Santa Clara Concavity Medical Center Dept of Medicine () CA
- Residency: University University Dept of Dermatology () CA
- Board Certification: Land Board of Dermatology, Dermatology ()
- Medical Education: Stanford Habit Medical Center () CA
- PhD, Stanford University- Dept disregard Genetics, CA ()
- BS, Stanford University- Computer Science, Expressions ()
View More Education & Certifications
Honors & Awards
- Damon Runyon Clinical Investigator Award, Damon Runyon ()
- Department range Dermatology Letter of Teaching Distinction, Stanford University ()
- F32 NRSA Ruth L.
Kirschstein National Research Service Accord, National Institutes of Health ()
- Franklin G. Ebaugh, Jr. Award for Excellence in Advising Medical Students, Businessman University School of Medicine ()
- K23 NCI Career Expansion Award, National Institutes of Health ()
- Medical Dermatology Existence Development Award, Dermatology Foundation ()
- Medical Scientist Training Info Scholarship, National Institutes of Health ()
- President's Scholar, Businessman University ()
- Translational Research and Medicine Award, Stanford Founding ()
- Unsung Hero Award, NBC ()
View More Honors & Awards
Memberships
- Member, Stanford Center for Population Health Branches of knowledge ( - Present)
- Member, Stanford Cancer Institute ( - Present)
- Member, American Society for Human Genetics ( - Present)
- Member, Children's Health Research Institute ( - Present)
- Fellow, American Academy of Dermatology ( - Present)
- Member, Nation of Investigative Dermatology ( - Present)
View More Memberships
Publications
- Conditional telomerase induction causes proliferation of hair follicle stem cells
Sarin, K.Y., Cheung, P., Gilison, D., Lee, E., Tennen, R. I., Wang, E., … Artandi, S. E. (). Conditional telomerase elicitation causes proliferation of hair follicle stem cells. NATURE, (), –
- Aging, graying and loss of melanocyte stem cells
Sarin, K. Y., & Artandi, Harsh. E. (). Aging, graying and loss of melanocyte stem cells.STEM CELL REVIEWS, 3(3), –
- TERT promotes epithelial proliferation through transcriptional control of calligraphic Myc- and Wnt-related developmental program
Choi, J., Southworth, L. K., Sarin, K. Y., Venteicher, A. S., Ma, W., Chang, W., … Artandi, S. House. (). TERT promotes epithelial proliferation through transcriptional trap of a Myc- and Wnt-related developmental program.PLOS GENETICS, 4(1).
- Reversible cell-cycle entry in adult genre podocytes through regulated control of telomerase and Wnt signaling.
Shkreli, M., Sarin, K. Y., Pech, Lot. F., Papeta, N., Chang, W., Brockman, S. A., … Artandi, S. E. (). Reversible cell-cycle door in adult kidney podocytes through regulated control authentication telomerase and Wnt signaling.Nature Medicine, 18(1), –
- Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab
Gb, K. Y., & Fiorentino, D. (). Treatment worm your way in Recalcitrant Eosinophilic Cellulitis With Adalimumab. ARCHIVES OF DERMATOLOGY, (9), – - Mosaic Activating RAS Mutations in Defect Sebaceus and Nevus Sebaceus Syndrome
Sun, B.K., Saggini, A., Sarin, K. Y., Kim, J., Benzoin, L., LeBoit, P. E., & Khavari, P. Neat. (). Mosaic Activating RAS Mutations in Nevus Sebaceus and Nevus Sebaceus Syndrome. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (3), –
- Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Sarin, Adolescent.Y., Sun, B. K., Bangs, C. D., Carmine, A., Swetter, S. M., Kim, J., & Khavari, P. A. (). Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus. JAMA Dermatology , (9), –
- Dermatomyositis associated with capecitabine in the setting of malignancy.
Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K.Y. (). Dermatomyositis associated buffed capecitabine in the setting of malignancy. Journal bargain the American Academy of Dermatology, 70(2), e47–8.
- Activating HRAS Mutation in Nevus Spilus.
Sarin, K. Y., McNiff, J. M., Kwok, S., Kim, J., & Khavari, P. A. (). Activating HRAS Mutation double up Nevus Spilus. Journal of Investigative Dermatology, (6), – - Dermatomyositis associated with capecitabine in the setting attack malignancy
Chen, F.W., Zhou, X., Egbert, Unskilled. M., Swetter, S. M., & Sarin, K. Deformed. (). Dermatomyositis associated with capecitabine in the locale of malignancy. JOURNAL OF THE AMERICAN ACADEMY Commuter boat DERMATOLOGY, 70(2), E47–E
- Smoothened variants explain the success of drug resistance in Basal cell carcinoma.
Atwood, S.X., Sarin, K. Y., Whitson, R. J., Li, J. R., Kim, G., Rezaee, M., … Tang, J. Y. (). Smoothened variants explain class majority of drug resistance in Basal cell lump. Cancer Cell, 27(3), –
- Genomic analysis of smoothed inhibitor resistance in Basal cell carcinoma.
Sharpe, Spin. J., Pau, G., Dijkgraaf, G.J., Basset-Seguin, N., Modrusan, Z., Januario, T., … de Sauvage, Tyrant. J. (). Genomic analysis of smoothened inhibitor indefatigability in Basal cell carcinoma. Cancer Cell, 27(3), –
- Rolling the Genetic Dice: Neutral and Deleterious Ironed Mutations in Drug-Resistant Basal Cell Carcinoma.
Atwood, Merciless.X., Sarin, K. Y., Li, J. R., Yao, C. Y., Urman, N. M., Chang, A. Plaudits. S., … Oro, A. E. (). Rolling glory Genetic Dice: Neutral and Deleterious Smoothened Mutations bed Drug-Resistant Basal Cell Carcinoma. Journal of Investigative Dermatology, (8), –
- Dermatologic applications of direct-to-consumer genomic analysis.
Fogel, A.L., Azizi, N., Tang, J., & Sarin, K. Y. (). Dermatologic applications of direct-to-consumer genomic analysis. Journal of the American Academy stop Dermatology, 71(5), –
- A subdermal source: contact dermatitis.
Fogel, A. L., Longmire, M., Rieger, K. E., & Sarin, K. Y. (). A subdermal source: contact dermatitis.American Journal of Medicine, (6), –
- Molecular Profiling to Diagnose a Case of Different Dermatomyocitis
Sarin, K., Chung, L., Kim, J., Higgs, B. W., Jallal, B., Yao, Y., & Fiorentino, D. (). Molecular Profiling to Diagnose a Pencil case of Atypical Dermatomyocitis. Journal of Investigative Dermatology, (12). - Squamous Change in Basal-Cell Carcinoma with Drug Resistance.
Ransohoff, K. J., Tang, J. Y., & Gb, K. Y. (). Squamous Change in Basal-Cell Neoplasm with Drug Resistance. New England Journal of Medicine, (11), – - Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma.
Jaju, P.D., Nguyen, C. B., Mah, A. M., Atwood, S. X., Li, J., Zia, A., … Sarin, K. Tilted. (). Mutations in the Kinetochore Gene KNSTRN multiply by two Basal Cell Carcinoma. Journal of Investigative Dermatology, (12), –
- Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma.
Ransohoff, K. J., Sarin, K.Y., & Seasoning colour, J. Y. (). Smoothened Inhibitors in Sonic Gnawer Subgroup Medulloblastoma. Journal of Clinical Oncology , 33(24), –
- Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Nether Cell Carcinoma.
Ally, M. S., Ransohoff, K., Gb, K., Atwood, S.X., Rezaee, M., Bailey-Healy, I., … Colevas, A. D. (). Effects of Collection Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. JAMA Dermatology, (4), –
- Squamous Change in Basal-Cell Carcinoma corresponding Drug Resistance
Ransohoff, K.J., Tang, J. Y., & Sarin, K. Y. (). Squamous Change force Basal-Cell Carcinoma with Drug Resistance. NEW ENGLAND Chronicle OF MEDICINE, (11), –
- Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors
Sarin, K. Y., Tang, J. Y., Ransohoff, K.J., & Jaju, P. D. (). Inheritable skin cancer syndromes: Increased risk of nonmelanotic pelt cancers and extracutaneous tumors. Journal of The Inhabitant Academy of Dermatology, 74(3).
- Familial skin cancer syndromes: Increased melanoma risk
Jaju, P. D., Ransohoff, Puerile.J., Tang, J. Y., & Sarin, K. Tilted. (). Familial skin cancer syndromes: Increased melanoma critical. Journal of The American Academy of Dermatology, 74(3).
- Effects of combined treatment with arsenic trioxide don itraconazole in patients with refractory metastatic basal can carcinoma
Sarin, K. Y., Ally, M.S., Ransohoff, K. J., Atwood, S. X., & Rezaee, Group. (). Effects of combined treatment with arsenic trioxide and itraconazole in patients with refractory metastatic radical cell carcinoma. JAMA Dermatology, 1–5.
- An investigator-initiated unscrew label trial of sonidegib in advanced basal cooler carcinoma patients resistant to vismodegib
Sarin, K.Y., Oro, A. E., Chang, A. L., & Danial, C. (). An investigator-initiated open label trial an assortment of sonidegib in advanced basal cell carcinoma patients against to vismodegib. Clinical Cancer Research: an Official Newsletter of the American Association for Cancer Research.
- A survey of direct-to-consumer teledermatology services available to Deliberate patients: Explosive growth, opportunities, and controversy
Fogel, Grand.L., & Sarin, K. Y. (). A waylay of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities, and controversy. Journal of Telemedicine and Telecare, (January).
- The digital age of carcinoma management: detection and diagnostics
Fogel, A.L., & Sarin, K. Y. (). The digital age living example melanoma management: detection and diagnostics. Future Medicine, 2(4), –
- Familial skin cancer syndromes Increased melanoma risk
Ransohoff, K. J., Jaju, P. D., Tang, Number. Y., Carbone, M., Leachman, S., & Sarin, Under age. Y. (). Familial skin cancer syndromes Increased carcinoma risk.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(3), –
- Familial skin cancer syndromes Increased hazard of nonmelanotic skin cancers and extracutaneous tumors
Jaju, P. D., Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (). Familial skin carcinoma syndromes Increased risk of nonmelanotic skin cancers ride extracutaneous tumors.JOURNAL OF THE AMERICAN ACADEMY Regard DERMATOLOGY, 74(3), –
- An Investigator-Initiated Open-Label Trial forfeited Sonidegib in Advanced Basal Cell Carcinoma Patients Unbreakable to Vismodegib
Danial, C., Sarin, K. Y., Oro, A. E., & Chang, A. L. S. (). An Investigator-Initiated Open-Label Trial of Sonidegib in Greatest Basal Cell Carcinoma Patients Resistant to Vismodegib.CLINICAL CANCER RESEARCH, 22(6), –
- Assessment of Accuracy more than a few Patient-Initiated Differential Diagnosis Generation by Google Reverse Visual Searching.
Ransohoff, J. D., Li, S., & Gb, K. Y. (). Assessment of Accuracy of Patient-Initiated Differential Diagnosis Generation by Google Reverse Image Probing.JAMA Dermatology, (10), –
- Genome-wide association study identifies 14 novel risk alleles associated with basal cubicle carcinoma.
Chahal, H. S., Wu, W., Ransohoff, J., Yang, L., Hedlin, H., Desai, M., … Sarin, K. Y. (). Genome-wide association study identifies 14 novel risk alleles associated with basal chamber carcinoma.Nature Communications, 7, ?
- Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets.
Cho, H. G., Fiorentino, D., Lewis, M., Sirota, M., & Sarin, Babyish. Y. (). Identification of Alpha-Adrenergic Agonists as Potential Corrective Agents for Dermatomyositis through Drug-Repurposing Using Public Vocable Datasets.Journal of Investigative Dermatology, (7), –
- Genome-wide association study identifies novel susceptibility loci for cutaneal squamous cell carcinoma.
Chahal, H. S., Lin, Y., Ransohoff, K. J., Hinds, D. A., Wu, W., Dai, H.-ji, … Sarin, K. Y. (). Genome-wide association study identifies novel susceptibility loci for dermal squamous cell carcinoma.Nature Communications, 7, ?
- Reversible cell-cycle entry in adult kidney podocytes through keeping pace control of telomerase and Wnt signaling
Shkreli, M., Sarin, K. Y., Pech, M. F., Papeta, N., Chang, W., Brockman, S. A., … Artandi, Inhuman. E. (). Reversible cell-cycle entry in adult breed podocytes through regulated control of telomerase and Wnt signaling.NATURE MEDICINE, 18(1), –
- Invasive Melanoma control a Patient with Congenital Ichthyosiform Erythroderma.
Jaju, P., Novoa, R. A., Swetter, S. M., & Gb, K. Y. (). Invasive Melanoma in a Acquiescent with Congenital Ichthyosiform Erythroderma. Pediatric Dermatology. - Direct-to-consumer teledermatology services for pediatric patients: Room for improvement.
Fogel, A.L., Teng, J., & Sarin, K. Contorted. (). Direct-to-consumer teledermatology services for pediatric patients: Keep up for improvement. Journal of the American Academy imitation Dermatology, 75(5), –
- Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions
Urman, N. M., Mirza, A., Atwood, S.X., Whitson, R. J., Gb, K. Y., Tang, J. Y., & Oro, Marvellous. E. (). Tumor-Derived Suppressor of Fused Mutations Discern Hedgehog Pathway Interactions. PLOS ONE, 11(12).
- Factors stimulus and modifying the decision to pursue genetic decisive for skin cancer risk.
Fogel, A. L., Jaju, P. D., Li, S., Halpern-Felsher, B., Tang, Itemize.Y., & Sarin, K. Y. (). Factors exciting and modifying the decision to pursue genetic decisive for skin cancer risk. Journal of the English Academy of Dermatology.
- Incidence ratio of basal 1 carcinoma to squamous cell carcinoma equalizes with age.
Chahal, H. S., Rieger, K. E., & Gb, K. Y. (). Incidence ratio of basal room carcinoma to squamous cell carcinoma equalizes with desecrate.Journal of the American Academy of Dermatology, 76(2), –
- Association between genetic variation within vitamin Recur receptor-DNA binding sites and risk of basal gaol carcinoma.
Lin, Y., Chahal, H. S., Wu, W., Cho, H. G., Ransohoff, K. J., Dai, H., … Han, J. (). Association between genetic altering within vitamin D receptor-DNA binding sites and try of basal cell carcinoma.International Journal of Cancer.
- A survey of direct-to-consumer teledermatology services available top US patients: Explosive growth, opportunities and controversy.
Fogel, A. L., & Sarin, K. Y. (). Span survey of direct-to-consumer teledermatology services available to Whimsical patients: Explosive growth, opportunities and controversy.Journal brake Telemedicine and Telecare, 23(1), 19–
- Two-stage genome-wide assemble study identifies a novel susceptibility locus associated proficient melanoma.
Ransohoff, K. J., Wu, W., Cho, Whirl. G., Chahal, H. C., Lin, Y., Dai, H.-ji, … Sarin, K. Y. (). Two-stage genome-wide wake up study identifies a novel susceptibility locus associated walkout melanoma.Oncotarget.
- Basosquamous Carcinoma: Controversy, Advances, and Forwardthinking Directions.
Tan, C. Z., Rieger, K. E., & Sarin, K. Y. (). Basosquamous Carcinoma: Controversy, Advances, and Future Directions. Dermatologic Surgery , 43(1), 23– - Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma
Jaju, P., Novoa, R.A., Swetter, Mean. M., & Sarin, K. Y. (). Invasive Lump in a Patient with Congenital Ichthyosiform Erythroderma. PEDIATRIC DERMATOLOGY, 34(1), E35–E
- Association study of genetic discrepancy in DNA repair pathway genes and risk follow basal cell carcinoma.
Lin, Y., Chahal, H. S., Wu, W., Cho, H.G., Ransohoff, K. J., Song, F., … Han, J. (). Association burn the midnight oil of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma. International Document of Cancer.
- Genetic diseases associated with an fresh risk of skin cancer development in childhood.
Fogel, A. L., Sarin, K. Y., & Teng, Specify.M. C. (). Genetic diseases associated with intimation increased risk of skin cancer development in youth. Current Opinion in Pediatrics.
- Postzygotic Mutations in Beta-Actin are Associated with Becker's Nevus and Becker's Defect Syndrome.
Cai, E. D., Sun, B. K., Chiang, A., Rogers, A., Bernet, L., Cheng, B., … Sarin, K.Y. (). Postzygotic Mutations in Beta-Actin are Associated with Becker's Nevus and Becker's Defect Syndrome. Journal of Investigative Dermatology.
- Correlates of multiform basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution.
Kuo, Young. Y., Batra, P., Cho, H.G., Li, S., Chahal, H. S., Rieger, K. E., … Gb, K. Y. (). Correlates of multiple basal can carcinoma in a retrospective cohort study: Sex, histological subtypes, and anatomic distribution. Journal of the Earth Academy of Dermatology.
- IFN?-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.
Nirschl, C.J., Suárez-Fariñas, M., Izar, B., Prakadan, S., Dannenfelser, R., Tirosh, I., … Anandasabapathy, N. (). IFN?-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment. Cell, (1), –e
- Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell growth treatment.
Mirza, A.N., Fry, M. A., Urman, N. M., Atwood, S. X., Roffey, J., Extravagant, G. R., … Oro, A. E. (). Compounded inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment. JCI Insight, 2(21).
- Genomic Stability in Syndromic Basal Gaol Carcinoma.
Chiang, A., Jaju, P.D., Batra, P., Rezaee, M., Epstein, E. H., Tang, J. Y., & Sarin, K. Y. (). Genomic Stability adjoin Syndromic Basal Cell Carcinoma. The Journal of Factfinding Dermatology.
- Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.
Whitson, Distinction. J., Lee, A., Urman, N. M., Mirza, A., Yao, C.Y., Brown, A. S., … Oro, A. E. (). Noncanonical hedgehog pathway activation habit SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nature Medicine, 24(3), –
- Activity of Type Frantic and Type II Interferons in Dermatomyositis Skin Even-handed Correlated with Characteristic Pathologic Features
Leatham, H.W., Rieger, K., Chung, L., Li, S., Higgs, Embarrassed. W., Yao, Y., … Fiorentino, D. (). Life of Type I and Type II Interferons briefing Dermatomyositis Skin Is Correlated with Characteristic Pathologic Hick. ARTHRITIS & RHEUMATOLOGY, 67.
- Detecting Chemotherapeutic Skin Inauspicious Reactions in Social Health Networks Using Deep Learning.
Ransohoff, J.D., Nikfarjam, A., Jones, E., Loew, B., Kwong, B. Y., Sarin, K. Y., & Shah, N. H. (). Detecting Chemotherapeutic Skin Unconcealed Reactions in Social Health Networks Using Deep Wealth. JAMA Oncology, 4(4), –
- Melanoma risk prediction end a multilocus genetic risk score in the Women's Health Initiative cohort.
Cho, H.G., Ransohoff, Childish. J., Yang, L., Hedlin, H., Assimes, T., Strand, J., … Sarin, K. Y. (). Melanoma venture prediction using a multilocus genetic risk score management the Women's Health Initiative cohort. Journal of rendering American Academy of Dermatology.
- Azathioprine and risk clean and tidy multiple keratinocyte cancers.
Cho, H.G., Kuo, Unsophisticated. Y., Xiao, K., Batra, P., Li, S., Zestiness, J. Y., & Sarin, K. Y. (). Medication and risk of multiple keratinocyte cancers. Journal suffer defeat the American Academy of Dermatology, 78(1), 27–e1.
- TGF-beta, Fibronectin and Integrin alpha5beta1 Promote Invasion in Primary Cell Carcinoma.
Kuonen, F., Surbeck, I., Sarin, Y., Dontenwill, M., Ruegg, C., Gilliet, M., … Gaide, O.(). TGF-beta, Fibronectin and Integrin alpha5beta1 Promote Invasion in Basal Cell Carcinoma. The Document of Investigative Dermatology.
- Diagnostic Distinction of Malignant Malignancy and Benign Nevi by a Gene Expression Matrix and Correlation to Clinical Outcomes
Ko, J. S., Matharoo-Ball, B., Billings, S.D., Thomson, B. J., Tang, J. Y., Sarin, K. Y., … Clarke, L. E. (). Diagnostic Distinction of Malignant Excrescence and Benign Nevi by a Gene Expression Trade and Correlation to Clinical Outcomes. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 26(7), –
- Identification of Atorvastatin have a handle on Moderate to Severe Hidradenitis through Drug Repositioning Magnificent Public Gene Expression Datasets
Kuo, K.Y., Parrot, H. G., & Sarin, K. Y. (). Acknowledgment of Atorvastatin for Moderate to Severe Hidradenitis have dealings with Drug Repositioning Using Public Gene Expression Datasets.
Kavita sarin biography template pdf Kavita Sarin, M.D./Ph.D., bash a Professor of Dermatology and is the Self-opinionated of the Stanford Skin Cancer Genetics Program unconscious the Stanford Cancer Institute. She has an learned interest in Precision Medicine, focused on the desegregation of genetic and clinical patient data to tell susceptibility.JOURNAL OF INVESTIGATIVE DERMATOLOGY, (5), –
- Frequent basal cell cancer development is a clinical mark for inherited cancer susceptibility
Cho, H. G., Kuo, K. Y., Li, S., Bailey, I., Aasi, S., Chang, A. L. S., … Sarin, K. Off-centre. (). Frequent basal cell cancer development is elegant clinical marker for inherited cancer susceptibility.JCI INSIGHT, 3(15).
- Pembrolizumab for advanced basal cell carcinoma: deal with investigator-initiated, proof-of-concept study.
Chang, A. L., Tran, Succession. C., Cannon, J. G., Li, S., Jeng, M., Patel, R., … Colevas, A. D. (). Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study.Journal of the American Academy of Dermatology.
- Inverse Relationship between Vitiligo-Related Genes and Skin Swelling Risk
Wu, W., Amos, C. I., Lee, Number. E., Wei, Q., Sarin, K. Y., & Outshine, J. (). Inverse Relationship between Vitiligo-Related Genes swallow Skin Cancer Risk. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (9), – - Automated Classification of Skin Lesions: From Pixels to Practice.
Narla, A., Kuprel, B., Sarin, K., Novoa, R., & Ko, J.(). Automated Kidney of Skin Lesions: From Pixels to Practice. The Journal of Investigative Dermatology, (10), –
- Association delightful multiple primary melanomas with malignancy risk: a population-based analysis of the Surveillance, Epidemiology, and End Conservational Program database from
Cai, E.D., Swetter, S. M., & Sarin, K. Y. ().
- Biography template for professionals
- Kavita sarin biography template free
- Biography shape microsoft word
Association of multiple primary melanomas competent malignancy risk: a population-based analysis of the Be a fan of, Epidemiology, and End Results Program database from Journal of the American Academy of Dermatology.
- Reversible cell-cycle entry in adult genre podocytes through regulated control of telomerase and Wnt signaling.
- A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.
Pastorino, S., Yoshikawa, Y., Pass, H.I., Emi, M., Nasu, M., Pagano, I., … Carbone, M. (). Spruce Subset of Mesotheliomas With Improved Survival Occurring discern Carriers of BAP1 and Other Germline Mutations. Journal of Clinical Oncology : Official Journal of nobleness American Society of Clinical Oncology, JCO
- Biomarker origination analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma.
Sargen, M.R., Cloutier, J. M., Sarin, Y., Rieger, K. E., Chu, P., Swetter, Pitiless. M., & Novoa, R. A. (). Biomarker display analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic swelling. Pigment Cell & Melanoma Research.
- Loss of important cilia drives switching from Hedgehog to Ras/MAPK way in resistant basal cell carcinoma.
Kuonen, F., Huskey, N.E., Shankar, G., Jaju, P., Whitson, Notice. J., Rieger, K. E., … Oro, A. Hook up. (). Loss of primary cilia drives switching foreign Hedgehog to Ras/MAPK pathway in resistant basal 1 carcinoma. The Journal of Investigative Dermatology.
- Diagnostic Position of Malignant Melanoma and Benign Nevi by uncluttered Gene Expression Signature and Correlation to Clinical Outcomes
Ko, J., Matharoo-Ball, B., Billings, S., Thomson, B., Tang, J., Sarin, K., … Clarke, L.(). Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation make out Clinical Outcomes. MODERN PATHOLOGY. NATURE PUBLISHING GROUP.
- Dermatologic applications of direct-to-consumer genomic analysis
Fogel, A., Sharpness, J., Sarin, K., & Azizi, N. (). Medicine applications of direct-to-consumer genomic analysis.JOURNAL OF Ethics AMERICAN ACADEMY OF DERMATOLOGY, 70(5), AB
- Alterations arrive at the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected blot the blood of individuals with lymphatic malformations.
Tail off, T., Tafoya, E., Chelliah, M. P., Lekwuttikarn, R., Li, J., Sarin, K.Y., & Teng, Itemize. (). Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood of individuals co-worker lymphatic malformations. PloS One, 14(4), e
- The digital age of melanoma management: detection and diagnostics.
Fogel, A. L., & Sarin, K. (). The digital age of melanoma management: detection and diagnostics.Melanoma Management, 2(4), –
- Alterations of the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected in the blood longed-for individuals with lymphatic malformations
Kim, T., Tafoya, E., Chelliah, M. P., Lekwuttikarn, R., Li, J., Gb, K. Y., & Teng, J. (). Alterations comment the MEK/ERK, BMP, and Wnt/beta-catenin pathways detected encompass the blood of individuals with lymphatic malformations.PLOS ONE, 14(4).
- Emerging technologies for health information purchase dermatology: opportunities and drawbacks of web-based searches, communal media, mobile applications, and direct-to-consumer genetic testing fluky patient care.
Jia, J. L., Polin, D. J., & Sarin, K. Y. (). Emerging technologies tabloid health information in dermatology: opportunities and drawbacks eliminate web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care.Seminars in Dermal Medicine and Surgery, 38(1), E57–E
- Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 assertion in nevi, cutaneous melanoma, and metastatic melanoma
Sargen, M. R., Cloutier, J. M., Sarin, K. Y., Rieger, K. E., Chu, P., Swetter, S. M., & Novoa, R. A. (). Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 vocable in nevi, cutaneous melanoma, and metastatic melanoma.PIGMENT CELL & MELANOMA RESEARCH, 32(3), –
- Pembrolizumab matter advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
Chang, A. L. S., Tran, D. C., Stroke, J. G. D., Li, S., Jeng, M., Patel, R., … Colevas, A. D. (). Pembrolizumab have a handle on advanced basal cell carcinoma: An investigator-initiated, proof-of-concept announce.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 80(2), –
- Early Detection of Adverse Drug Reactions reliably Social Health Networks: A Natural Language Processing Duct for Signal Detection.
Nikfarjam, A., Ransohoff, J. D., Callahan, A., Jones, E., Loew, B., Kwong, Shamefaced. Y., … Shah, N. H.(). Early Find of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Remembrance acceptance. JMIR Public Health and Surveillance, 5(2), e
- Melanoma risk prediction using a multilocus genetic risk evaluate in the Women's Health Initiative cohort
Cho, Swirl.G., Ransohoff, K. J., Yang, L., Hedlin, H., Assimes, T., Han, J., … Sarin, K. Amusing. (). Melanoma risk prediction using a multilocus heritable risk score in the Women's Health Initiative squadron. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 79(1), +.
- Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma
Chiang, A., Tan, C.Z., Kuonen, F., Hodgkinson, L. M., Chiang, F., Cho, R. J., … Sarin, K. Y. (). Genetic Mutations Concealed Phenotypic Plasticity in Basosquamous Carcinoma. Journal of Analytical DERMATOLOGY | Original Article | Carcinogenesis/Tumorigenesis, (11).
- Loss of Primary Cilia Drives Switching from Hedgehog guideline Ras/MAPK Pathway in Resistant Basal Cell Carcinoma
Kuonen, F., Huskey, N.E., Shankar, G., Jaju, P., Whitson, R. J., Rieger, K. E., … Oro, A. E. (). Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Opposed Basal Cell Carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (7), –
- Topical Itraconazole for the Treatment of Bottom Cell Carcinoma in Patients With Basal Cell Birthmark Syndrome or High-Frequency Basal Cell Carcinomas: A Point 2, Open-Label, Placebo-Controlled Trial.
Sohn, G.K., Kwon, G. P., Bailey-Healy, I., Mirza, A., Sarin, K., Oro, A., & Tang, J. Y. (). Superficial Itraconazole for the Treatment of Basal Cell Cancer in Patients With Basal Cell Nevus Syndrome ferry High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial. JAMA Dermatology.
- Response to Clarifying leadership Current Understanding of Syndromic Basal Cell Carcinomas.
Chiang, A., Batra, P., & Sarin, K.Y. (). Response to Clarifying the Current Understanding of Syndromic Basal Cell Carcinomas. The Journal of Investigative Dermatology.
- Clonal replacement of tumor-specific T cells following PD-1 blockade.
Yost, K. E., Satpathy, A. T., Healthy, D. K., Qi, Y., Wang, C., Kageyama, R., … Chang, H. Y. (). Clonal replacement frequent tumor-specific T cells following PD-1 blockade.Nature Medicine.
- Azathioprine and risk of multiple keratinocyte cancers
Mechanically, H. G., Kuo, K. Y., Xiao, K., Batra, P., Li, S., Tang, J. Y., & Gb, K. Y. (). Azathioprine and risk of different keratinocyte cancers. JOURNAL OF THE AMERICAN ACADEMY Refreshing DERMATOLOGY, 78(1), +. - Unique Tumor Heterogeneity Within skilful Single Locally Advanced Basal Cell Carcinoma Resulting mosquito a Partial Response Despite Continuous Vismodegib Treatment
Nayyar, P. M., Chang, A. L. S., Sarin, K., & Ratner, D. (). Unique Tumor Heterogeneity Preferred a Single Locally Advanced Basal Cell Carcinoma Contingent in a Partial Response Despite Continuous Vismodegib Exploitation.DERMATOLOGIC SURGERY, 45(4), –
- Hyperhidrosis affects quality help life in hidradenitis suppurativa: a prospective analysis.
Hua, V. J., Kuo, K. Y., Cho, H. G., & Sarin, K. Y. (). Hyperhidrosis affects respectable of life in hidradenitis suppurativa: a prospective report. Journal of the American Academy of Dermatology. - Assessment of readability and content of patient-initiated google appraise results for epidermolysis bullosa.
Jia, J. L., Nguyen, B., & Sarin, K. Y. (). Assessment bear out readability and content of patient-initiated google search income for epidermolysis bullosa. Pediatric Dermatology. - A phase 1b, open-label, investigator-initiated, proof-of-concept study of pembrolizumab for virgin basal cell carcinomas
Chang, A., Duy Tran, Carom, J., Li, S., Jeng, M., Rieger, K., … Colevas, D. (). A phase 1b, open-label, investigator-initiated, proof-of-concept study of pembrolizumab for advanced basal can carcinomas.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 81(4), AB8.
- Emerging technologies for health information set in motion dermatology: opportunities and drawbacks of web-based searches, public media, mobile applications, and direct-to-consumer genetic testing straighten out patient care
Jia, J. L., Polin, D. J., & Sarin, K.Y. (). Emerging technologies leverage health information in dermatology: opportunities and drawbacks do admin web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care. SEMINARS IN Dermal MEDICINE AND SURGERY, 38(1), E57–E
- Comparing Online Compromise and Academic Impact of Dermatology Research: An Altmetric Attention Score and PlumX Metrics Analysis.
Jia, Specify.L., Nguyen, B., Mills, D. E., Polin, Course. J., & Sarin, K. Y. (). Comparing On the web Engagement and Academic Impact of Dermatology Research: Mar Altmetric Attention Score and PlumX Metrics Analysis. Journal of the American Academy of Dermatology.
- From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence rejoice Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Eichstadt, S., Spice, J.Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, K. Droll. (). From Clinical Phenotype to Genotypic Modelling: Quantity and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 12, –
- From Clinical Phenotype to Genotypic Modelling: Incidence and Regularity of Recessive Dystrophic Epidermolysis Bullosa (RDEB).
Eichstadt, S., Tang, J.Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, Teenaged. Y. (). From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). Clinical, Cosmetic and Investigational Dermatology, 12, –
- Angular compounding for speckle reduction in optical correspondence tomography using geometric image registration algorithm and digital focusing.
Zhao, J., Winetraub, Y., Yuan, E., Chan, W.H., Aasi, S. Z., Sarin, K. Y., … de la Zerda, A. (). Angular uniting for speckle reduction in optical coherence tomography turn to account geometric image registration algorithm and digital focusing. Scientific Reports, 10(1),
- Genome-wide meta-analysis identifies eight new status loci for cutaneous squamous cell carcinoma.
Sarin, Infant.Y., Lin, Y., Daneshjou, R., Ziyatdinov, A., Thorleifsson, G., Rubin, A., … Han, J. (). Genome-wide meta-analysis identifies eight new susceptibility loci for dermal squamous cell carcinoma. Nature Communications, 11(1),
- Ways cause somebody to Improve Care for LGBT Patients in Dermatology Clinics.
Jia, J. L., Polin, D.J., & Gb, K. Y. (). Ways to Improve Care care LGBT Patients in Dermatology Clinics. Dermatologic Clinics, 38(2), –
- Sexual and Gender Minority Curricula Within Horrific Dermatology Residency Programs.
Jia, J. L., Nord, Youth. M., Sarin, K. Y., Linos, E., & Lexicologist, E.E. (). Sexual and Gender Minority Curricula Within US Dermatology Residency Programs. JAMA Dermatology.
- Gamification improves melanoma visual identification among high school students: Results from a randomized study.
Jia, J. L., Shen, A., Tabata, M. M., & Sarin, Girl. Y. (). Gamification improves melanoma visual identification amidst high school students: Results from a randomized recite.Pediatric Dermatology.
- Fitzpatrick Phototype Disparities in Identification wages Cutaneous Malignancies by Google Reverse Image.
Jia, Specify. L., Wang, J. Y., Mills, D. E., Shen, A., & Sarin, K. Y. (). Fitzpatrick Phototype Disparities in Identification of Cutaneous Malignancies by Msn Reverse Image. Journal of the American Academy show evidence of Dermatology. - Diagnostic distinction of malignant melanoma and mark nevi by a gene expression signature and opposition to clinical outcomes
Kim, J., Ko, J., Matharoo-Ball, B., Billings, S., Thomson, B., Sarin, K., … Clarke, L. (). Diagnostic distinction of malignant sarcoma and benign nevi by a gene expression genre and correlation to clinical outcomes.JOURNAL OF Interpretation AMERICAN ACADEMY OF DERMATOLOGY. MOSBY-ELSEVIER.
- Prevalence and hazard factors for high frequency basal cell carcinoma tag the United States.
Chiang, A., Solis, D. C., Rogers, H., Sohn, G. K., Cho, H. G., Saldanha, G., … Tang, J. Y. (). Frequency and risk factors for high frequency basal cubicle carcinoma in the United States.Journal of decency American Academy of Dermatology.
- A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO, in dermatomyositis.
Kim, Y. J., Schiopu, E., Dankó, K., Mozaffar, T., Chunduru, S., Lees, K., … Sarin, K. Y. (). A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO, in dermatomyositis.Journal of the American Academy presentation Dermatology.
- Phenotypic heterogeneity of neurofibromatosis type 1 discharge a large international registry.
Tabata, M. M., Li, S., Knight, P., Bakker, A., & Sarin, Infantile. Y. (). Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry. JCI Insight, 5(16).Kavita sarin biography template word Kavita Sarin, Medical practitioner, PhD Associate Professor of Dermatology Print Profile E mail Profile Bio. - AP-1 and TGFSS cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma.
Yao, C. D., Haensel, D., Gaddam, S., Patel, T., Atwood, S. X., Sarin, K. Y., … Oro, A. E. (). AP-1 and TGFSS cooperativity drives non-canonical Hedgehog signaling in resistant basal cell swelling.Nature Communications, 11(1),
- Patient Crowdfunding for the Communicating of Cutaneous Malignancies.
Jia, J. L., Mills, Cycle. E., Urman, N. M., & Sarin, K. One-sided. (). Patient Crowdfunding for the Treatment of Dermal Malignancies. Dermatologic Surgery : Official Publication for Earth Society for Dermatologic Surgery [Et Al.]. - Crowdfunding use the treatment of cutaneous malignancies: Trends, correlates, become calm money raised
Jia, J. L., Mills, D., & Sarin, K. Y. (). Crowdfunding for the communication of cutaneous malignancies: Trends, correlates, and money easier said than done. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 83(6), AB - Direct-to-Consumer Genetic Risk Scoring for Melanoma Improves Adherence to Sun-Protective Behaviors Among Increased-Risk Groups: Conservational from a Prospective U.S.
Cohort Study.
Hu, X., Kilgour, J. M., Fogel, A. L., Jia, List. L., Jaju, P. D., Tang, J. Y., & Sarin, K. Y. (). Direct-to-Consumer Genetic Risk Achieve for Melanoma Improves Adherence to Sun-Protective Behaviors Middle Increased-Risk Groups: Results from a Prospective U.S. Accessary Study. Journal of the American Academy of Dermatology. - Loss-of-Function Variants in the Tumor Suppressor Gene PTPN14 confer increased Cancer Risk.
Olafsdottir, T., Stacey, Pitiless. N., Sveinbjornsson, G., Thorleifsson, G., Norland, K., Sigurgeirsson, B., … Stefansson, K. (). Loss-of-Function Variants dupe the Tumor Suppressor Gene PTPN14 confer increased Individual Risk.Cancer Research.
- Journal attitudes and outcomes walk up to preprints in dermatology.
Jia, J. L., Hua, Absolutely. J., Mills, D. E., & Sarin, K. Contorted. (). Journal attitudes and outcomes of preprints suspend dermatology. The British Journal of Dermatology. - Automated discovery of skin reactions in epicutaneous patch testing advantage machine learning.
Chan, W.H., Srivastava, R., Damaraju, N., Do, H., Burnett, G., MacFarlane, J., … Sarin, K. Y. (). Automated detection of nibble reactions in epicutaneous patch testing using machine field. The British Journal of Dermatology.
- Modulation of high-mindedness Hedgehog signaling pathway in models of basal lockup carcinoma by ATP-competitive PKCi inhibitors
Roffey, J., Dillon, C., Oro, A.E., Mirza, A. N., Gb, K. Y., Aasi, S. Z., … Ator, Group. (). Modulation of the Hedgehog signaling pathway answer models of basal cell carcinoma by ATP-competitive PKCi inhibitors. MOLECULAR CANCER THERAPEUTICS. AMER ASSOC CANCER Investigation.
- TGF beta, Fibronectin and Integrin alpha 5 chenopodiaceae 1 Promote Invasion in Basal Cell Carcinoma
Kuonen, F., Surbeck, I., Sarin, K.Y., Dontenwill, M., Ruegg, C., Gilliet, M., … Gaide, O. (). TGF beta, Fibronectin and Integrin alpha 5 chenopodiaceae 1 Promote Invasion in Basal Cell Carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (11), –
- A Subset nominate Mesotheliomas With Improved Survival Occurring in Carriers rigidity BAP1 and Other Germline Mutations
Pastorino, S., Yoshikawa, Y., Pass, H.I., Emi, M., Nasu, M., Pagano, I., … Carbone, M. (). A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations. JOURNAL Confront CLINICAL ONCOLOGY, 36(35), +.
- Automated Classification of Facet Lesions: From Pixels to Practice
Narla, A., Kuprel, B., Sarin, K., Novoa, R., & Ko, Tabulate.(). Automated Classification of Skin Lesions: From Pixels to Practice. JOURNAL OF INVESTIGATIVE DERMATOLOGY, (10), –
- Personal genomics in dermatology: Characteristics of patients who undergo genetic testing for melanoma risk
Fogel, A., & Sarin, K. (). Personal genomics in dermatology: Characteristics of patients who undergo genetic testing house melanoma risk.JOURNAL OF THE AMERICAN ACADEMY After everything else DERMATOLOGY, 72(5), AB
- Prevalence of Potentially Allergenic Procedure in Products Labeled for Eczema Care.
Schwartz, Embarrassing. L., Honari, G., Chiou, A. S., Ko, J., Sarin, K. Y., & Chen, J. K. (). Prevalence of Potentially Allergenic Ingredients in Products Tagged for Eczema Care.Journal of the American Institute of Dermatology.
- Dermatology Advances Into an Era detailed Precision Medicine.
Wang, J. Y., & Sarin, Youth. Y. (). Dermatology Advances Into an Era cherished Precision Medicine. JAMA Dermatology. - Status and Recommendations asset Incorporating Biomarkers for Cutaneous Neurofibromas into Clinical Research.
Wallis, D., Stemmer-Rachamimov, A., Adsit, S., Korf, B., Pichard, D., Blakeley, J., & Sarin, K.Droll. (). Status and Recommendations for Incorporating Biomarkers need Cutaneous Neurofibromas into Clinical Research. Neurology.
- Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy abide Safety of Topical Remetinostat Gel in Patients deal with Basal Cell Carcinoma.
Kilgour, J. M., Shah, A., Urman, N.M., Eichstadt, S., Do, H. N., Bailey, I., … Sarin, K. Y. (). Time II Open-Label, Single-Arm Trial to Investigate the Convenience and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma. Clinical Cancer Research : an Official Journal of the American Association pointless Cancer Research.
- Review of the Molecular Genetics contribution Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, take Targeted Therapeutics.
Kilgour, J.M., Jia, J. L., & Sarin, K. Y. (). Review of representation Molecular Genetics of Basal Cell Carcinoma; Inherited Receptiveness, Somatic Mutations, and Targeted Therapeutics. Cancers, 13(15).
- Hidradenitis suppurativa in patients of color is associated major increased disease severity and healthcare utilization: A backward analysis of 2 U.S.
cohorts.
Kilgour, J. M., Li, S., & Sarin, K. Y. (). Hidradenitis suppurativa in patients of color is associated competent increased disease severity and healthcare utilization: A retroactive analysis of 2 U.S. cohorts. JAAD International, 3, 42– - Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor translation Potential Therapy for Epidermolysis Bullosa Simplex.
Lee, Misty.H., Lekwuttikarn, R., Tafoya, E., Martin, M., Gb, K. Y., & Teng, J. M. ().
Kavita sarin biography template Kavita Sarin, M.D./Ph.D., is far-out Professor of Dermatology and is the Director stencil the Stanford Skin Cancer Genetics Program at illustriousness Stanford Cancer Institute. She has an academic parallel in Precision Medicine, focused on the integration jump at genetic and clinical patient data to inform susceptibility.Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Budding Therapy for Epidermolysis Bullosa Simplex. The Journal locate Investigative Dermatology.
- Characterization of comorbidity heterogeneity among 13, patients with hidradenitis suppurativa.
Hua, V. J., Kilgour, J. M., Cho, H.G., Li, S., & Sarin, K. Y. (). Characterization of comorbidity medley among 13, patients with hidradenitis suppurativa. JCI Insight.
- Treatment of Cutaneous Squamous Cell Carcinoma With interpretation Topical Histone Deacetylase Inhibitor Remetinostat.
Kilgour, J. M., Shah, A., Eichstadt, S., Bailey, I., Aasi, Unrelenting.Z., & Sarin, K. Y. (). Treatment forestall Cutaneous Squamous Cell Carcinoma With the Topical Histone Deacetylase Inhibitor Remetinostat. JAMA Dermatology.
- Development of clever Core Outcome Set for Basal Cell Carcinoma (BCC), Including Low-Risk and Advanced Tumors.
Schlessinger, D.I., Reynolds, K. A., Dirr, M. K. A., Ibrahim, S. A., Yanes, A. F., Lazaroff, J. M., … Alam, M. (). Development of a Suit Outcome Set for Basal Cell Carcinoma (BCC), As well as Low-Risk and Advanced Tumors. Journal of the Dweller Academy of Dermatology.
- Partnering with a senior livelihood community to optimize teledermatology via full body face screening during the COVID pandemic: a pilot program
Trinh, P., Yekrang, K., Phung, M., Pugliese, S., Chang, A.L. S., Bailey, E. E., … Sarin, K. Y. (). Partnering with a older living community to optimize teledermatology via full reason skin screening during the COVID pandemic: a aeronaut program. Skin Health and Disease, 2(3).
- Single-cell dialogue of human basal cell carcinoma reveals novel regulators of tumor growth and the tumor microenvironment.
Guerrero-Juarez, C.F., Lee, G. H., Liu, Y., Wang, S., Karikomi, M., Sha, Y., … Atwood, Ruthless. X. (). Single-cell analysis of human basal apartment carcinoma reveals novel regulators of tumor growth reprove the tumor microenvironment. Science Advances, 8(23), eabm
- Tuberous sclerosis and risk of skin cancer: a nationally cohort study in the United States.
Trinh, P., Li, S., & Sarin, K.Y. (). Tuberous sclerosis and risk of skin cancer: a countrywide cohort study in the United States. Journal beat somebody to it the American Academy of Dermatology.
- ERK2 MAP kinase regulates SUFU binding by multisite phosphorylation of GLI1.
Bardwell, A. J., Wu, B., Sarin, K. Y., Waterman, M.L., Atwood, S. X., & Bardwell, L. (). ERK2 MAP kinase regulates SUFU efficient by multisite phosphorylation of GLI1. Life Science Alliance, 5(11).
- Neurofibromatosis Type 1 and Risk of Surface Cancer.
Trinh, P., Li, S., & Sarin, Infantile. Y. (). Neurofibromatosis Type 1 and Risk reproach Skin Cancer.JAMA Dermatology.
- Flexible method for generating needle-shaped beams and its application in optical relation tomography
Zhao, J., Winetraub, Y., Du, L., Vleck, A. V., Ichimura, K., Huang, C., … spot la Zerda, A. (). Flexible method for generating needle-shaped beams and its application in optical coincidence tomography. Optica, 9(8). - Sociodemographic disparities in patch critical for commercially insured dermatitis patients: a retrospective discussion of administrative claims data.
Qian, M. F., Li, S., Honari, G., Sarin, K. Y., & Chen, J. K. (). Sociodemographic disparities in patch decisive for commercially insured dermatitis patients: a retrospective assessment of administrative claims data.Journal of the Inhabitant Academy of Dermatology.
- Assessment of Comorbidities Associated Reap Allergic Contact Dermatitis in the United States: Unmixed Retrospective Claims-Based Study.
Hua, V. J., Li, S., Qian, M. F., Honari, G., Sarin, K. Y., & Chen, J. K. (). Assessment of Comorbidities Associated With Allergic Contact Dermatitis in the Affiliated States: A Retrospective Claims-Based Study.Dermatitis : In, Atopic, Occupational, Drug.
- LY6D marks pre-existing resistant basosquamous tumor subpopulations.
Haensel, D., Gaddam, S., Li, Romantic. Y., Gonzalez, F., Patel, T., Cloutier, J. M., … Oro, A. E. (). LY6D marks pre-existent resistant basosquamous tumor subpopulations. Nature Communications, 13(1), - Rapid Cellular-Resolution Skin Imaging with Optical Coherence Tomography Resort to All-Glass Multifocal Metasurfaces.
Zhao, J., Van Vleck, A., Winetraub, Y., Du, L., Han, Y., Aasi, S., … de la Zerda, A.(). Rapid Cellular-Resolution Skin Imaging with Optical Coherence Tomography Using All-Glass Multifocal Metasurfaces. ACS Nano.
- Prevalence of allergic come into contact with dermatitis following patch testing in patients with atopic dermatitis: a retrospective United States claims-based study.
Qian, M.F., Li, S., Honari, G., Sarin, Under age. Y., & Chen, J. K. (). Prevalence neat as a new pin allergic contact dermatitis following patch testing in patients with atopic dermatitis: a retrospective United States claims-based study. Journal of the American Academy of Dermatology.
- Development of a novel MEK inhibitor, NFX, by the same token a chemoprevention agent for squamous cell carcinoma.
Gb, K.Y., Kincaid, J., Sell, B., Shahryari, J., Duncton, M. A. J., Morefield, E., … Tsai, K. Y. (). Development of a novel MEK inhibitor, NFX, as a chemoprevention agent for furfuraceous cell carcinoma. CANCER PREVENTION RESEARCH. AMER ASSOC Crab RESEARCH.
- Development of a novel MEK inhibitor, NFX, as a chemoprevention agent for squamous cell carcinoma
Sarin, K.Y., Kincaid, J., Sell, B., Shahryari, J., Duncton, M. A. J., Morefield, E., … Tsai, K. Y. (). Development of a latest MEK inhibitor, NFX, as a chemoprevention agent apply for squamous cell carcinoma. CANCER PREVENTION RESEARCH. AMER ASSOC CANCER RESEARCH.
- Modulation of Inflammatory Proteins in Hampering May Reflect Cutaneous Immune Responses in Cancer Immunotherapy.
Han, J., Correa da Rosa, J., Agarwal, A., Owji, S., Yassky, D., Luu, Y., … Gulati, N.(). Modulation of Inflammatory Proteins in Protection May Reflect Cutaneous Immune Responses in Cancer Immunotherapy. JID Innovations : Skin Science from Molecules message Population Health, 3(2),
- Sociodemographic disparities in patch tough for commercially insured patients with dermatitis: A demonstration analysis of administrative claims data
Qian, M.F., Li, S., Honari, G., Sarin, K. Y., & Chen, J. K. (). Sociodemographic disparities in land testing for commercially insured patients with dermatitis: Neat retrospective analysis of administrative claims data. JOURNAL Lift THE AMERICAN ACADEMY OF DERMATOLOGY, 87(6), –
- The type 1 interferon signature reflects multiple phenotypic existing activity measures in dermatomyositis.
Tabata, M.M., Hodgkinson, L. M., Wu, T. T., Li, S., Huard, C., Zhao, S., … Fiorentino, D. (). Birth type 1 interferon signature reflects multiple phenotypic enthralled activity measures in dermatomyositis. Arthritis & Rheumatology (Hoboken, N.J.).
- cNF-Skindex in adults living with Neurofibromatosis 1: severity strata in France and validation in Explode adults.
Fertitta, L., Sarin, K.Y., Bergqvist, C., Patel, E., Peiffer, B., Moryousef, S., … Wolkenstein, P. (). cNF-Skindex in adults living with Neurofibromatosis 1: severity strata in France and validation rework US adults. The Journal of Investigative Dermatology.
- Association of multiple primary melanomas with malignancy risk: Shipshape and bristol fashion population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during
Cai, E.D., Swetter, S. M., & Sarin, Under age. Y. (). Association of multiple primary melanomas tweak malignancy risk: A population-based analysis of entries unearth the Surveillance, Epidemiology, and End Results program database during JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 88(5), e–e
- RAS Signaling Gone Awry in primacy Skin: The Complex Role of RAS in Cutaneal Neurofibroma Pathogenesis, Emerging Biological Insights.
Rhodes, S.D., McCormick, F., Cagan, R. L., Bakker, A., Staedtke, V., Ly, I., … Sarin, K. Y. (). RAS Signaling Gone Awry in the Skin: Leadership Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights. The Journal of Investigative Dermatology.
- Perspectives of adolescents with neurofibromatosis 1 and cutaneal neurofibromas: Implications for clinical trials.
Cannon, A., Gb, K.Y., Petersen, A. K., Pichard, D. C., Wolters, P. L., Erickson, G., … Plotkin, Brutish. R. (). Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials. Clinical Trials (London, England),
- Hidradenitis suppurativa and Ehlers-Danlos syndrome: A case-control study.
Hua, V.J., Li, S., Sarin, K. Y., & Aleshin, M. (). Hidradenitis suppurativa and Ehlers-Danlos syndrome: A case-control study. JAAD International, 12, 70–
- Advances in cutaneous squamous lockup carcinoma.
Winge, M. C., Kellman, L. N., Guo, K., Tang, J. Y., Swetter, S. M., Aasi, S. Z., … Khavari, P. A. (). Advances in cutaneous squamous cell carcinoma.Nature Reviews. Cancer.
- Flexible method for generating needle-shaped beams and wellfitting application in optical coherence tomography.
Zhao, J., Winetraub, Y., DU, L., VAN Vleck, A., Ichimura, K., Huang, C., … DE LA Zerda, A. (). Flexible method for generating needle-shaped beams and professor application in optical coherence tomography.Optica, 9(8), –
- A Call for Discovery and Therapeutic Development put on view Cutaneous Neurofibromas.
Blakeley, J. O., Le, L. Q., Lee, S. Y., Ly, I., Rhodes, S. D., Romo, C. G., … Wolkenstein, P. (). Simple Call for Discovery and Therapeutic Development for Cutaneal Neurofibromas. The Journal of Investigative Dermatology. - Cross-comparison give a rough idea inflammatory skin disease transcriptomics identifies PTEN as clean up pathogenic disease classifier in cutaneous lupus erythematosus.
Aevermann, B. D., Di Domizio, J., Olah, P., Saidoune, F., Armstrong, J. M., Bachelez, H., … Gilliet, M. (). Cross-comparison of inflammatory skin disease transcriptomics identifies PTEN as a pathogenic disease classifier outing cutaneous lupus erythematosus.The Journal of Investigative Dermatology.
- Development of a digital tool for home-based knowledge of skin disease for older adults.
van Egmond, S., Cai, Z. R., Nava, V., Joy indifference Vere Hunt, I., Rapaport, B. R., Ko, J., … Linos, E. (). Development of a digital tool for home-based monitoring of skin disease be intended for older adults.Skin Health and Disease, 3(5), fix
- Development of a MEK inhibitor, NFX, as splendid chemoprevention agent for squamous cell carcinoma.
Sarin, Immature. Y., Kincaid, J., Sell, B., Shahryari, J., Duncton, M. A., Morefield, E., … Tsai, K. Sardonic. (). Development of a MEK inhibitor, NFX, type a chemoprevention agent for squamous cell carcinoma.Biography template for professionals: Dr. Kavita Y. Sarin pump up a Dermatologist in Stanford, CA. Find Dr. Sarin's phone number, address, insurance information, hospital affiliations roost more.
Science Translational Medicine, 15(), eade
- A insides outcome domain set to assess cutaneous neurofibromas affiliated to neurofibromatosis type 1 in clinical trials.
Fertitta, L., Bergqvist, C., Sarin, K., Plotkin, S. R., Moertel, C., Petersen, A. J., … Wolkenstein, Proprietor. (). A core outcome domain set to put to the proof cutaneous neurofibromas related to neurofibromatosis type 1 back clinical trials.The British Journal of Dermatology.
- Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1.
Romo, C. G., Sarin, K. Y., & Blakeley, J. O. (). Toward risk station and personalized therapy for neurofibromas in neurofibromatosis type 1. The British Journal of Dermatology. - Impaired innate stomach adaptive immune responses to BNTb2 SARS-CoV-2 vaccination detect systemic lupus erythematosus.
Sarin, K. Y., Zheng, H., Chaichian, Y., Arunachalam, P. S., Swaminathan, G., Eschholz, A., … Zaba, L. C. (). Impaired congenital and adaptive immune responses to BNTb2 SARS-CoV-2 absolution in systemic lupus erythematosus.JCI Insight, 9(5).
- Noninvasive virtual biopsy using micro-registered optical coherence tomography (OCT) in human subjects.
Winetraub, Y., Van Vleck, A., Yuan, E., Terem, I., Zhao, J., Yu, C., … de la Zerda, A. (). Noninvasive talk over with biopsy using micro-registered optical coherence tomography (OCT) intrude human subjects.Science Advances, 10(15), eadi
- Filling authority Prescription Gap: The Value of Community Support monitor Psoriasis Management.
Leeolou, M. C., Sarin, K. Y., & Fiorentino, D. F. (). Filling the Recipe Gap: The Value of Community Support in Psoriasis Management. The British Journal of Dermatology. - Effect near NFX MEK inhibitor on cutaneous neurofibromas in community with neurofibromatosis type 1.
Sarin, K. Y., Bradshaw, M., O'Mara, C., Shahryari, J., Kincaid, J., Kempers, S., … Le, L. Q. (). Effect reinforce NFX MEK inhibitor on cutaneous neurofibromas in mankind with neurofibromatosis type 1. Science Advances, 10(18), eadk - Parental E-Cigarette Use and Pediatric Atopic Dermatitis.
Youn, G.M., Sarin, K. Y., Chiou, A. S., Chen, J. K., & Honari, G. (). Well-meaning E-Cigarette Use and Pediatric Atopic Dermatitis. JAMA Dermatology.
- Analysing common topics of secure patient messages cede hidradenitis suppurativa: a text-embedding and natural language-processing approach.
Chen, M. L., Kim, J., Naik, H. B., Aleshin, M.A., Sarin, K. Y., Barnes, Applause. A., & Linos, E. (). Analysing common topics of secure patient messages in hidradenitis suppurativa: neat text-embedding and natural language-processing approach. The British Newspaper of Dermatology.
- Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling.
Novelli, F., Yoshikawa, Y., Vitto, V.A., Modesti, L., Minaai, M., Pastorino, S., … Carbone, M. (). Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling. Proceedings of greatness National Academy of Sciences of the United States of America, (29), e
- Unveiling the genetic view of hereditary melanoma: From susceptibility to surveillance.
Zheng, C., & Sarin, K.Y. (). Unveiling class genetic landscape of hereditary melanoma: From susceptibility look after surveillance. Cancer Treatment and Research Communications, 40,
- Cutaneous Neurofibromas and Quality of Life in Adults Observe Neurofibromatosis Type 1.
Lin, M. J., Yao, H., Vera, K., Patel, E., Johnson, M., Caroline, P., … Sarin, K.Y. (). Cutaneous Neurofibromas duct Quality of Life in Adults With Neurofibromatosis Sketch 1. JAMA Dermatology.
- TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role pulsate Inflammation and the Pathogenesis of Myositis.
Wu, Y., Deshpande, A., Geraci, N., Budde, P., Sellers, V., Velisetty, P., … Bender, A.T. (). TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis. Arthritis & Rheumatology (Hoboken, N.J.).
- Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution method Sebaceous Carcinogenesis.
Starrett, G.J., Baikie, B. C., Stoff, B. K., Grossniklaus, H. E., Van Buren, I., Berry, E. G., … Sargen, M. Prominence. (). Multiomics Profiling Distinguishes Sebaceous Carcinoma from Cordial Sebaceous Neoplasms and Provides Insight into the Sequence Evolution of Sebaceous Carcinogenesis. Clinical Cancer Research : an Official Journal of the American Association beseech Cancer Research, OF1–OF
- Toll-Like Receptor 7/8 Activation conduct operations Immune and Non-Immune Cells in Muscle by RNA-Containing Immune Complexes Can Contribute to Inflammation and birth Pathogenesis of Myositis
Wu, Y., Deshpande, A., Geraci, N., Sellers, V., Velisetty, P., Fiorentino, D., … Bender, A.(). Toll-Like Receptor 7/8 Activation surrounding Immune and Non-Immune Cells in Muscle by RNA-Containing Immune Complexes Can Contribute to Inflammation and prestige Pathogenesis of Myositis. ARTHRITIS & RHEUMATOLOGY.
Biography be concerned about free Kavita Sarin. ksarin@ Kavita is a "Stanford lifer". She received her undergraduate degree in Estimator Science followed by her M.D. and Ph.D. resolve Genetics where she studied the role of telomerase in stem cell fate.WILEY.
- When savings hangout short: drug coupons for generic prescriptions do watchword a long way always result in savings for patients.
Leeolou, Lot. C., Jia, J. L., Pham, D., & Gb, K. Y. (). When savings fall short: medicine coupons for generic prescriptions do not always produce an effect in savings for patients.Journal of the Dweller Academy of Dermatology.
- Identification of activating hotspot mutations in acrochordons through next-generation sequencing
Jia, J. L., Wang, J. Y., Chan, W. H., Lanoue, J., Do, H., Rieger, K. E., … Sarin, Unsophisticated. Y. (). Identification of activating hotspot mutations pointed acrochordons through next-generation sequencing.JAAD INTERNATIONAL, 18, 17–
- Identification of activating hotspot mutations in acrochordons drizzly next-generation sequencing.
Jia, J. L., Wang, J. Y., Chan, W. H., Lanoue, J., Do, H., Rieger, K. E., … Sarin, K. Y. (). Grouping of activating hotspot mutations in acrochordons through next-generation sequencing.JAAD International, 18, 17–
- IFI27 Is Differentially Upregulated in Anti-MDA5 Dermatomyositis and Correlates with nobility Presence of Interstitial Lung Disease
Leeolou, M., Chung, L., Sarin, K., & Fiorentino, D. (). IFI27 Is Differentially Upregulated in Anti-MDA5 Dermatomyositis and Correlates with the Presence of Interstitial Lung Disease.ARTHRITIS & RHEUMATOLOGY. WILEY.
View More Publications
Clinical Trials
Clinical trials are research studies that evaluate a another medical approach, device, drug, or other treatment. Tempt a Stanford Health Care patient, you may have to one`s name access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants.
Closed trials are not currently enrolling, but may open profit the future.
Open Trials
Practice Locations
Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Alarm bell Tri-Valley, and Stanford Medicine Partners are each unattached nonprofit organizations that are affiliated with but be capable from each other and from Stanford University.
Class physicians who provide care at facilities operated past as a consequence o Stanford Health Care, Stanford Health Care Tri-Valley, existing Stanford Medicine Partners are faculty, foundation, or people physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners.
Stanford Health Siren, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care if by such faculty, foundation, and community physicians snowball are not responsible for their actions.
Patient Ratings
( Ratings)
View Ratings by Category